Hello, and welcome to a health podocy. I'm your host, Rob Lott. I'll admit that I have a relatively simple understanding of the relationship between brand name drugs and generic drugs. Generally, I ...

The practice of a brand manufacturer delaying the launch of an authorized generic medication has declined over recent years, and its effects on the market can be both positive and negative depending ...

The use of generic drugs continues to rise. Only seven years ago, 38 percent of U.S. drugs were generics. The forecast for 2007 is 48 percent. For the most part, this is good news for the generic drug ...

And the authorized generic controversy arrives at an already challenging time for the generics industry. Pricing on generics has flattened. A number of generic launches have been delayed because ...

Brand-name drugmakers are increasingly making generic versions of their own drugs, a strategy that keeps drug costs high and stifles competition, critics of the practice told Kaiser Health News. The ...

Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...

Authorized Generics: Why Mylan Would Compete With Itself in the EpiPen Market As part of an attempt to quell the furor over its more than 400% price increase for its life-saving EpiPen, Mylan ...

(RTTNews) - Specialty pharmaceutical company Collegium Pharmaceutical, Inc. (COLL) announced Monday it has entered into an authorized generic agreement with Hikma Pharmaceuticals USA Inc., pursuant to ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--YARAL Pharma Inc., (YARAL Pharma) is proud to celebrate the first anniversary of its entry into the United States generics marketplace. YARAL Pharma is the U.S.

After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued this past January, some parents are reporting challenges in obtaining the generic versions of the ...

WASHINGTON — Once a bit player but now an indispensable part of the U.S. health care market, the generic drug industry is about to hit an unprecedented growth spurt. Over the next two years, patents ...

Add Yahoo as a preferred source to see more of our stories on Google. One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially ...